ARNOLD & PORTER KAYE SCHOLER LLP for ADAPTIVE BIOTECHNOLOGIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2021 Commerce-Justice-Science Appropriations regarding the Eliminating Kickbacks in Recovery Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| CJ MAHLER | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Health Issues HCR
Issues related to lab analysis and review of diagnostics and lab developed tests, including the VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and 21st Century Cures 2.0 Concept Paper.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| CJ MAHLER | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Medicare/Medicaid MMM
Issues related to lab analysis and review of diagnostics and lab developed tests, including VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and the 21st Century Cures 2.0 Concept Paper.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| CJ MAHLER | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.